Publication: Recombinant human thrombomodulin inhibits neutrophil extracellular trap formation in vitro
Open/View Files
Date
2016
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
BioMed Central
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Shimomura, Y., M. Suga, N. Kuriyama, T. Nakamura, T. Sakai, Y. Kato, Y. Hara, et al. 2016. “Recombinant human thrombomodulin inhibits neutrophil extracellular trap formation in vitro.” Journal of Intensive Care 4 (1): 48. doi:10.1186/s40560-016-0177-9. http://dx.doi.org/10.1186/s40560-016-0177-9.
Research Data
Abstract
The aim of this study was to investigate the effects of recombinant human-soluble thrombomodulin (rTM) on lipopolysaccharide (LPS)-induced, platelet-dependent neutrophil extracellular trap (NET) formation (NETosis). Human peripheral blood neutrophils and platelets were co-incubated with or without LPS (0.2 μg/ml) in the presence and absence of rTM (2 μg/ml). NETosis was confirmed by immunostaining and confocal microscopy. In the absence of platelets, LPS did not induce NETosis in the neutrophils. NETosis, however, was induced by LPS when neutrophils were co-cultured with platelets (64 % of neutrophils). Notably, rTM was able to fully inhibit NETosis in neutrophils cultured with platelets and in the presence of LPS. rTM did not induce NETosis in this co-culture system (p < 0.01 versus LPS in the absence of rTM). These results show that rTM can suppress LPS-induced platelet-dependent NETosis in vitro.
Description
Other Available Sources
Keywords
Disseminated intravascular coagulation, Innate immunity, Neutrophil extracellular traps, Sepsis, Thrombomodulin
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service